Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 4/2024

Edition 3/2024

Edition 2/2024

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

J Hepatol. 2024;80(4):576–85

Long-term outcomes of patients with autoimmune hepatitis-induced cirrhosis after immunosuppressive treatment

Eur J Gastroenterol Hepatol. 2024;36(6):742–9

Sex, genotype, and liver volume progression as risk of hospitalization determinants in autosomal dominant polycystic liver disease

Gastroenterology. 2024;166(5):902–14

A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis

J Hepatol. 2024;80(4):603–9

Endoscopic variceal ligation versus propranolol for the primary prevention of oesophageal variceal bleeding in patients with hepatocellular carcinoma: An open-label, 2-centre, randomised controlled trial

Gut. 2024;73(4):682–90

Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography

Hepatology. 2024;79(5):1048–64

The clinical and financial burden of non-hepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosis

Hepatology. 2024;79(4):813–28

Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections – Results from the ICA “Global Study” (EABCIR-Global Study)

Hepatology. 2024;79(5):1019–32

Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites

Hepatology. 2024;79(4):844–56